Ebola Outbreak in DRC Ituri — Bundibugyo Strain & Africa CDC Response

📋 What's Inside — 11 Sections

Click any section below to jump directly to its full notes

Core Concept & EVD Definition

Etymology, taxonomy, EVD vs EHF, key terms

Origin & Historical Evolution

1976 first outbreak, DRC's 17 outbreaks, key milestones

Scientific & Biological Profile

Filoviridae, transmission, symptoms, incubation, BSL-4

Key Statistics & Epidemiological Data

CFR by strain, major outbreaks, global comparisons

Strains Classification & Vaccine Matrix

5 species, 3 human-pathogenic strains, Ervebo, Zabdeno, gaps

Institutions & Global Response Bodies

Africa CDC, WHO, INRB, CEPI, Gavi, US CDC — roles

Geographical & Cross-Border Dimension

Ituri Province, DRC borders, Uganda spread, mining mobility

Current Affairs (May 2026)

Live outbreak data, Bundibugyo confirmed, Uganda case, Africa CDC

PYQ & Common Traps

Statement T/F table, 5+ examiner traps, species confusion

MCQ Practice

5 UPSC-style MCQs on BSL, species, vaccines, geography

Quick Revision

12 rapid-recall bullets + one-liner capsule

Core Concept & EVD Definition

What is Ebola Virus Disease (EVD)?

Definitional & Taxonomic Framework
Attribute	Detail
Full Name	Ebola Virus Disease (EVD); formerly Ebola Haemorrhagic Fever (EHF)
Causative Agents	Viruses of genus Ebolavirus (or Orthoebolavirus — updated ICTV nomenclature)
Family	Filoviridae (filamentous RNA viruses); includes genera Ebolavirus, Marburgvirus, Cuevavirus
Order	Mononegavirales
Genome	Single-stranded, negative-sense RNA; ~19 kb
Morphology	Filamentous, pleomorphic virion; 80 nm diameter, up to 14,000 nm in length
BSL Category	BSL-4 — highest biosafety level; no licensed treatment for all strains
Reservoir Host	Fruit bats of family Pteropodidae (probable natural reservoir — not confirmed for all species)
Type of Disease	Zoonotic viral haemorrhagic fever; acute-onset; no carrier state
Name Origin	Named after the Ebola River, near 1976 first outbreak site in Zaire (now DRC)

Key Terminology for UPSC

Terms frequently tested in Prelims
Term	Meaning	UPSC Relevance
Haemorrhagic Fever	Fever with internal/external bleeding due to vascular damage	Identifies EVD disease type
Zoonosis	Disease transmitted from animals to humans	EVD is a zoonotic disease — key classification
BSL-4	Biosafety Level 4 — requires highest containment (positive-pressure suits, isolated facilities)	MCQ on BSL levels — Ebola + Nipah both BSL-4
Ring Vaccination	Vaccinating contacts and contacts-of-contacts of confirmed cases	Strategy used with Ervebo in 2018–20 outbreak
PHEIC	Public Health Emergency of International Concern — WHO's highest alert	2014–16 West Africa and 2018–20 DRC declared PHEIC
CFR	Case Fatality Rate = Deaths / Confirmed Cases × 100	Ranges 25–90% across Ebola species
Spillover Event	Transmission from animal reservoir to human population	Initial human infection mechanism for EVD
INRB	Institut National de Recherche Biomédicale — DRC's national biomedical research institute	Lab that confirmed May 2026 Ituri outbreak

Filoviridae BSL-4 Zoonosis ssRNA Virus Haemorrhagic Fever Pteropodidae (Fruit Bats) Negative-Sense RNA PHEIC Ring Vaccination Mononegavirales

📌 Micro-Fact

EVD was renamed from "Ebola Haemorrhagic Fever" to "Ebola Virus Disease" in 2014 by WHO — because not all patients develop haemorrhage. The name "Ebola" itself comes from the Ebola River in what is now the DRC.

💡 Exam Tip

UPSC frequently tests the family (Filoviridae) and BSL level (BSL-4) in statement-type questions. Also note: Marburg virus also belongs to Filoviridae — a common pairing trap. Nipah virus is Paramyxoviridae, not Filoviridae.

Bottom Line: EVD = BSL-4 zoonotic disease; Family = Filoviridae; Genus = Ebolavirus; Natural reservoir = fruit bats (Pteropodidae); CFR = 25–90% depending on strain.

Origin & Historical Evolution

The Discovery: 1976

Ebola was first identified in 1976 in two nearly simultaneous outbreaks: one in Yambuku, Zaire (now DRC) near the Ebola River, and one in Sudan (now South Sudan). The viruses from both outbreaks were distinct — now known as Zaire ebolavirus and Sudan ebolavirus. The first recorded patient in Zaire was Mabalo Lokela, a 44-year-old schoolteacher. Initially mistaken for Marburg virus, it was confirmed as a new pathogen by the US CDC (Karl Johnson's team). The 1976 Zaire outbreak: 318 cases, 280 deaths (CFR: 88%).

1976

First two outbreaks simultaneously — Zaire (318 cases, 280 deaths) and Sudan (284 cases, 151 deaths). Two distinct species identified.

1989

Reston ebolavirus discovered in imported macaques from Philippines at a US lab in Reston, Virginia. First non-African Ebola species; not pathogenic to humans.

1994

Taï Forest ebolavirus identified in a researcher after performing autopsy on a chimpanzee in Côte d'Ivoire. Only one human case ever.

1995

Major outbreak in Kikwit, Zaire — 315 cases, 254 deaths (CFR: 81%). First large-scale international response effort.

2007

Bundibugyo ebolavirus (5th species) discovered — first outbreak in Bundibugyo District, Uganda; 56 cases, 37 deaths. Species named after district.

2014–2016

West Africa Epidemic — largest EVD outbreak in history. Guinea, Liberia, Sierra Leone. Over 28,600 cases; 11,325 deaths. WHO declared PHEIC in August 2014. Zaire strain.

2018–2020

DRC 10th outbreak — 3,470 cases, 2,287 deaths — second largest ever. Ituri and North Kivu provinces. WHO declared PHEIC July 2019. First use of Ervebo vaccine. Declared over June 2020.

Sep–Dec 2025

DRC 16th outbreak in Kasai Province — Zaire strain; 64 cases, 45 deaths. Declared over December 1, 2025 (WHO).

May 2026

DRC 17th outbreak — Ituri Province. Bundibugyo strain confirmed. 246 suspected cases, 65 deaths. Spread to Uganda (Kampala). Africa CDC convenes urgent coordination meeting May 15, 2026.

📌 Micro-Fact

DRC has experienced 17 Ebola outbreaks since 1976 — more than any other country. The 2014 Ebola epidemic in West Africa accelerated the creation of Africa CDC, which was formally established in 2016 and launched in January 2017.

💡 Exam Tip

Order of size: Largest = 2014–16 West Africa (28,600+ cases) → Second = 2018–20 DRC (3,470 cases) → Third = 2026 Ituri (246 suspected — ongoing). UPSC asks about "largest outbreak" frequently. Also: Bundibugyo ebolavirus was first found in Uganda (Bundibugyo District), NOT DRC — but the 2026 outbreak is in DRC.

Bottom Line: Ebola first identified 1976 (DRC + Sudan simultaneously); 5 species discovered through 1989–2007; DRC has had 17 outbreaks; largest ever = 2014–16 West Africa (28,600+ cases); 2026 Ituri outbreak = DRC's 17th.

Scientific & Biological Profile

Taxonomy & Classification

Complete Classification of Ebola Virus
Level	Name	Note
Order	Mononegavirales	Single-stranded negative-sense RNA viruses
Family	Filoviridae	Filamentous viruses; includes Ebola, Marburg, Cueva
Genus	Ebolavirus / Orthoebolavirus	Updated ICTV 2023 nomenclature
Related Genus	Marburgvirus	Causes Marburg Virus Disease; also BSL-4
Related Genus	Cuevavirus	Found in bats in Spain; not known to infect humans
Genome	ssRNA (−), 7 genes	Encodes: NP, VP35, VP40, GP, VP30, VP24, L protein
Key Surface Protein	Glycoprotein (GP)	Mediates host cell entry; target of vaccine antigens and antibody therapies

Transmission, Incubation & Symptoms

🦠 Transmission Pathways

Direct contact with blood, secretions, organs, body fluids of infected humans
Contact with contaminated objects (needles, bedding, clothing)
Handling/eating infected bush meat (chimpanzees, gorillas, forest antelope, porcupines)
Fruit bats (Pteropodidae) — probable reservoir/spillover host
Sexual transmission — semen of recovered males for up to 12 months post-recovery
Safe & Dignified Burials (SDB) critical — bodies of deceased are highly infectious
NOT airborne; NOT waterborne; NOT vector-borne (insect)

🤒 Clinical Course

Incubation: 2–21 days (avg. 8–10 days); no carrier state
Early symptoms: Sudden fever, fatigue, muscle pain, headache, sore throat
Later symptoms: Vomiting, diarrhoea, rash, impaired kidney & liver function
Haemorrhage: Internal/external bleeding in ~50% of cases (gums, stools)
Lab findings: Low WBC, low platelets, elevated liver enzymes
Patient is NOT infectious during incubation — only when symptomatic
Death: Due to multi-organ failure, typically 6–16 days post-symptom onset

BSL-4 & Containment

Biosafety Level Comparison (for UPSC context)
BSL Level	Risk	Examples	Protection
BSL-1	Minimal	E. coli (non-pathogenic)	Lab coat, gloves
BSL-2	Moderate	Hepatitis B, Influenza	Face shield, biosafety cabinet
BSL-3	Serious	Anthrax, SARS-CoV, Tuberculosis	Respirator, sealed lab
BSL-4	Extreme/Unknown	Ebola, Marburg, Nipah, Hendra	Positive-pressure suits; isolated facility

📌 Micro-Fact — India's BSL-4

India's first BSL-4 lab is at NIV Pune (National Institute of Virology). A second, first state-funded BSL-4 facility is being built in Gandhinagar, Gujarat (foundation stone laid January 13, 2026; cost ₹362 crore; under Gujarat Biotechnology Research Centre).

Treatment & Prevention

Current Approved Therapeutics & Their Targets
Name	Type	Targets	Status
Inmazeb (REGN-EB3)	Monoclonal antibody cocktail	Zaire ebolavirus GP	FDA approved 2020 — treatment
Ebanga (ansuvimab)	Human monoclonal antibody	Zaire ebolavirus GP	FDA approved 2020 — treatment
ZMapp	Antibody cocktail	Zaire ebolavirus	Used in 2014–16; not formally approved
Bundibugyo: No approved treatment	—	—	Key gap in 2026 outbreak

Supportive care (rehydration, symptom management, maintaining organ function) significantly improves survival rates even without specific antivirals.

💡 Exam Tip

UPSC tests: "Ebola does NOT spread through air/water/mosquito bites" — a common trap. Also: Ebola patient is NOT infectious during incubation period — only when symptomatic. The Glycoprotein (GP) on the viral envelope is the key target for both vaccines and antibody therapies.

Bottom Line: Family = Filoviridae; BSL-4; transmission = body fluids only (NOT airborne/waterborne); incubation = 2–21 days; no carrier state; Glycoprotein GP = vaccine target; Bundibugyo has NO approved vaccine or treatment.

Key Statistics & Epidemiological Data

1976

Year First Identified

DRC Outbreaks (1976–2026)

Ebolavirus Species

25–90%

CFR Range (all strains)

28,600+

Cases — 2014–16 West Africa

11,325

Deaths — 2014–16 West Africa

246

Suspected Cases — Ituri 2026

Deaths — Ituri 2026 (as of 15 May)

CFR by Ebolavirus Species

Case Fatality Rates across Ebola species (meta-analysis data, 1976–2022)
Species	CFR Range	Pooled CFR	Notable Outbreaks
Zaire ebolavirus (EBOV)	60–90%	~66.6%	1976 Zaire; 2014–16 West Africa; 2018–20 DRC
Sudan ebolavirus (SUDV)	40–60%	~48.5%	1976 Sudan; 2000 Uganda (425 cases)
Bundibugyo ebolavirus (BDBV)	25–40%	~32.8%	2007 Uganda (56 cases); 2012 DRC; 2026 Ituri (ongoing)
Taï Forest ebolavirus (TAFV)	0% (1 case)	—	1994 Côte d'Ivoire — 1 patient, recovered
Reston ebolavirus (RESTV)	N/A	N/A (not pathogenic to humans)	1989 Philippines/USA; monkeys only

Major Ebola Outbreaks — Data Table

Key outbreaks for Prelims rapid recall
Year	Location	Strain	Cases	Deaths	PHEIC?
1976	Zaire (DRC)	Zaire	318	280	No
1976	Sudan	Sudan	284	151	No
1995	Kikwit, DRC	Zaire	315	254	No
2007	Bundibugyo, Uganda	Bundibugyo	56	37	No
2014–16	West Africa (Guinea, Liberia, Sierra Leone)	Zaire	28,600+	11,325+	Yes (Aug 2014)
2018–20	North Kivu & Ituri, DRC	Zaire	3,470	2,287	Yes (Jul 2019)
Sep–Dec 2025	Kasai Province, DRC	Zaire	64	45	No
May 2026	Ituri Province, DRC (+ Uganda)	Bundibugyo	246 (suspected)	65	Under assessment

✅ Key Fact

WHO's average case fatality rate across all Ebola outbreaks is approximately 50%. However, this varies enormously — from under 30% (Bundibugyo 2007) to 88% (Zaire 1976). Early supportive care significantly reduces mortality.

⚠ Common Trap

The 2018–20 DRC outbreak was NOT the largest in history — that title belongs to the 2014–16 West Africa epidemic. The 2018–20 DRC outbreak was the second largest and the largest ever in DRC. Do not confuse these two in MCQs.

Bottom Line: Zaire = deadliest (CFR ~66%); Bundibugyo = lowest CFR of human-pathogenic strains (~33%); Reston = NOT pathogenic in humans; Largest outbreak = 2014–16 West Africa (28,600 cases); DRC total = 17 outbreaks since 1976.

Strains Classification & Vaccine Matrix

5 Species of Ebolavirus — Classification Table

All 5 Ebolavirus species — high-yield Prelims data
Species	Named After	Country of Discovery	Year	Human-Pathogenic?	Vaccine?
Zaire ebolavirus (EBOV)	Zaire (now DRC)	DRC	1976	Yes — most lethal	✅ Ervebo, Zabdeno/Mvabea
Sudan ebolavirus (SUDV)	Sudan	South Sudan	1976	Yes — moderate lethality	❌ No licensed vaccine (trials ongoing)
Bundibugyo ebolavirus (BDBV)	Bundibugyo District, Uganda	Uganda	2007	Yes — lowest CFR of 3	❌ No licensed vaccine
Taï Forest ebolavirus (TAFV)	Taï Forest, Côte d'Ivoire	Côte d'Ivoire	1994	Yes — only 1 human case ever	❌ No licensed vaccine
Reston ebolavirus (RESTV)	Reston, Virginia, USA	USA (from Philippine monkeys)	1989	No — not pathogenic to humans	N/A

Vaccine Matrix — Critical for 2026 UPSC

WHO-prequalified Ebola vaccines and their scope
Vaccine Name	Developer	Type	Dosing	Targets	Approved
Ervebo® (rVSV-ZEBOV)	Merck & Co.	Live attenuated recombinant (VSV vector)	Single dose	Zaire ebolavirus ONLY	EMA 2019; FDA 2019; WHO prequalified 2019
Zabdeno® (Ad26.ZEBOV)	Janssen (J&J)	Adenovirus 26 vector — prime dose	Dose 1 of 2-dose regimen (56 days apart)	Zaire ebolavirus ONLY	EMA 2020; WHO prequalified 2021
Mvabea® (MVA-BN-Filo)	Janssen (J&J)	Modified Vaccinia Ankara vector — boost dose	Dose 2 (given 8 weeks after Zabdeno)	Zaire (primary); Sudan, Marburg (partial)	EMA 2020; WHO prequalified 2021

⚠ KEY TRAP — 2026 Outbreak Angle

The 2026 Ituri outbreak involves Bundibugyo ebolavirus. Existing vaccines (Ervebo, Zabdeno/Mvabea) target Zaire ebolavirus — they are not effective against Bundibugyo. DRC has ~2,000 doses of Ervebo stockpiled, but these are useless for this strain. No approved vaccine or specific treatment exists for Bundibugyo. This is the central challenge of the 2026 outbreak.

Vaccine Strategy Context

✅ Ervebo — For Outbreaks (Ring Vaccination)

Single dose — immediate protection possible
84% effective (2018–20 real-world data)
Stockpile: ~500,000 doses in Switzerland
ICG (International Coordinating Group) manages stockpile access
SAGE (WHO) recommends for outbreak ring vaccination
Only Zaire strain

🔵 Zabdeno/Mvabea — Preventive Use

Two doses, 56 days apart — NOT ideal for outbreak settings
Recommended for pre-exposure vaccination of frontline/healthcare workers
Gavi (June 2024) opened access for lower-income countries for preventive use
Efficacy extrapolated from animal studies for non-Zaire coverage in Mvabea
Only Zaire strain primarily effective

📌 Micro-Fact — Genetic Gap

Bundibugyo and Zaire ebolaviruses are approximately 40% genetically different. This is why Zaire-targeting vaccines provide no cross-protection against Bundibugyo. Vaccines are designed around the surface Glycoprotein (GP), which differs significantly between species.

💡 Exam Tip

Remember: WHO prequalifies 2 vaccines for EVD — both target only Zaire strain. UPSC may ask: "Which vaccine is recommended for ring vaccination during Ebola outbreaks?" — Answer: Ervebo (rVSV-ZEBOV), single-dose. SAGE 2024 recommendation. Zabdeno/Mvabea requires 2 doses — not suitable for outbreak ring vaccination.

Bottom Line: 5 Ebolavirus species; 3 cause human outbreaks (Zaire, Sudan, Bundibugyo); only Zaire has approved vaccines (Ervebo + Zabdeno/Mvabea); 2026 Ituri = Bundibugyo — NO vaccine; Reston = NOT human-pathogenic; first discovered in Bundibugyo District, Uganda (2007).

Institutions & Global Response Bodies

Africa CDC — Profile

Africa CDC — Key Facts for UPSC
Attribute	Detail
Full Name	Africa Centres for Disease Control and Prevention (Africa CDC)
Parent Body	African Union (AU) — as an autonomous specialized institution since 2022
Headquarters	Addis Ababa, Ethiopia
Founded	Formally established by AU in January 2017 (26th AU Assembly approved in 2016)
Established As	Initially a specialized technical agency; upgraded to autonomous public health body in 2022
Catalyst	2014 West Africa Ebola epidemic accelerated its creation
Proposed By	Government of Ethiopia (2013) at AU TB/HIV Summit, Abuja
Director General	Dr. Jean Kaseya (DRC national; appointed February 2023; 4-year term)
Governing Board	19 members — 10 Health Ministers (one per AU region), AU Commission reps, civil society, private sector
New Power (2022)	Can now declare Public Health Emergencies of Continental Security (PHECS)
New HQ (2023)	New headquarters inaugurated in Addis Ababa, includes BSL-3 reference laboratory; built by China Civil Engineering Group Corporation
Regional Centres	5 Regional Collaborating Centres: Egypt (N. Africa), Nigeria (W. Africa), Gabon (C. Africa), Zambia (S. Africa), Kenya (E. Africa)

Key Institutions in EVD Response

Institutions involved in Ebola Outbreak Response
Institution	Type	Role in EVD Response
Africa CDC	AU Autonomous Agency	Surveillance coordination, emergency operations, PHECS declaration, cross-border coordination
WHO (AFRO)	UN Agency	PHEIC declaration, technical support, vaccine procurement, laboratory confirmation
INRB	DRC National Lab	Institut National de Recherche Biomédicale — primary lab for sample testing in DRC (confirmed 2026 Ituri outbreak)
US CDC	US Federal Agency	Technical support, country office in DRC, contact tracing, surveillance
CEPI	Global PPP (based Oslo)	Coalition for Epidemic Preparedness Innovations — funds vaccine R&D for Ebola and other pathogens
Gavi	Vaccine Alliance (Geneva)	ICG stockpile of Ervebo; opened preventive vaccination for frontline workers in 2024
MSF (Médecins Sans Frontières)	NGO	Frontline clinical treatment, Ebola Treatment Units (ETUs)
IFRC	International Red Cross	Safe and Dignified Burials (SDB), community engagement
ICG	International Coordinating Group	Manages global stockpile of Ervebo; emergency vaccine allocation
World Bank / Gates Foundation	Financing Bodies	Emergency funding for outbreak response

Africa CDC — Key Powers & Structure

Africa CDC mandates and functions
Function/Power	Detail
Event-based Surveillance	Detect disease threats from informal/unstructured sources
IHR Support	Assist member states with International Health Regulations compliance
Emergency Ops	Deploy experts quickly (autonomy allows 24-hour deployment vs. months before 2022)
PHECS Declaration	Can declare Public Health Emergency of Continental Security (used for 2024 mpox outbreak)
Laboratory Network	Coordinates national public health labs; BSL-3 reference lab at HQ
PAVIA Initiative	Partnership for African Vaccine Manufacturing — target: 60% of vaccines used in Africa to be made in Africa by 2040

📌 Micro-Fact

Africa CDC's 2024 mpox response marked the first ever declaration of a Public Health Emergency of Continental Security (PHECS) — a new power granted by the 2022 AU statute revision. This is distinct from WHO's PHEIC — it is an Africa-level alert mechanism.

💡 Exam Tip

UPSC asks about: (1) Africa CDC HQ = Addis Ababa, Ethiopia — not DRC, not South Africa; (2) It is an AU institution — not a UN body; (3) WHO declares PHEIC; Africa CDC declares PHECS. These are frequently confused. CEPI is headquartered in Oslo, Norway; Gavi is in Geneva, Switzerland.

Bottom Line: Africa CDC = AU autonomous institution; HQ Addis Ababa; Director General = Dr. Jean Kaseya; triggered by 2014 Ebola; can declare PHECS; 5 regional centres; WHO declares PHEIC; INRB = DRC's key lab that confirmed 2026 Ituri outbreak.

Geographical & Cross-Border Dimension

DRC — Geographical Profile

DRC & Ituri Province — Key Geographic Facts
Parameter	Data
Full Name	Democratic Republic of the Congo (formerly Zaire until 1997)
Size	2nd largest country in Africa by area (after Algeria)
Capital	Kinshasa
Population	~100 million+ (largest Francophone country in the world)
Location	Central Africa; heart of the Congo Basin; equatorial rainforest
Neighbours (9)	Republic of Congo, Central African Republic, South Sudan, Uganda, Rwanda, Burundi, Tanzania, Zambia, Angola
Ituri Province	Northeastern DRC; capital = Bunia; mineral-rich (gold); borders Uganda & South Sudan
Distance Kinshasa–Ituri	>1,000 km (620+ miles) — extremely remote
Ituri: 2026 Outbreak Zones	Mongwalu (gold mining town) + Rwampara health zone; also Bunia city (suspected cases)

Cross-Border Risk Factors — 2026 Ituri Outbreak

🔴 Risk Amplifiers

Mining mobility: Mongwalu is a gold-mining town; constant influx of miners from multiple countries
Refugee movement: Ituri hosts internally displaced people (IDPs) due to armed conflict (ADF militants)
Insecurity: Allied Democratic Forces (ADF — IS-linked militants) active in Ituri; limits health worker access
Border proximity: Ituri directly borders Uganda and South Sudan
Urban cluster: Bunia (Ituri's capital) involved — urban settings accelerate spread
Already crossed: A Congolese man died in Kampala, Uganda on May 14, 2026 — first confirmed cross-border spread

✅ Response Advantages

DRC has highest experience — 17 outbreaks handled since 1976
INRB (national lab in Kinshasa) capable of rapid sequencing
WHO experts deployed to Ituri from May 5, 2026
Uganda screened at 22 entry points before confirmed spread
Africa CDC convened urgent regional meeting within 24 hours of confirmation
Strong institutional memory from 2018–20 response

Countries Most Affected by Ebola Historically — Global Map Data

Countries with significant EVD outbreaks
Country	Region	Notable Outbreak(s)	Strain(s)
DRC (Zaire)	Central Africa	17 outbreaks; 1976, 1995, 2018–20, 2026	Zaire, Sudan, Bundibugyo
Guinea	West Africa	Index case of 2014–16 West Africa epidemic	Zaire
Liberia	West Africa	2014–16 (hardest hit country)	Zaire
Sierra Leone	West Africa	2014–16	Zaire
Uganda	East Africa	2000 (Sudan strain, 425 cases); 2007 (Bundibugyo discovery); 2026 imported case	Sudan, Bundibugyo
South Sudan	East Africa	1976 (Sudan epidemic origin); at-risk in 2026	Sudan
Gabon	Central Africa	Multiple outbreaks 1994–2005	Zaire

📌 Micro-Fact — India's Preparedness

India's MoHFW conducted 5 sub-national EVD preparedness workshops in 2019 with WHO support (Bengaluru, Pune, Guwahati, Bhubaneswar, Delhi) training Rapid Response Teams (RRTs), airport health officers, and clinicians. India's Kerala state is watched closely given significant DRC-Uganda travel connections in the diaspora.

💡 Exam Tip

Remember: DRC = 2nd largest in Africa by area (not population — Nigeria is most populous). The Ebola River is in Équateur Province, DRC — NOT Ituri Province. The 2026 outbreak is in Ituri Province (northeast), while the 1976 outbreak was near Yambuku in Équateur Province (northwest). These geography questions appear in UPSC.

Bottom Line: Ituri Province = northeast DRC; capital = Bunia; borders Uganda & South Sudan; Mongwalu = gold mining zone = high mobility; Ebola already in Uganda (Kampala, May 14, 2026); DRC = 2nd largest African country; ADF militants complicate response.

Current Affairs — Ebola Ituri 2026 (May 2026 · Live Outbreak)

📊 Breaking — Africa CDC Confirmation · Africa CDC Official Statement · May 15, 2026

Africa CDC officially confirmed an Ebola Virus Disease (EVD) outbreak in Ituri Province, DRC on May 15, 2026. Preliminary results from INRB (Institut National de Recherche Biomédicale) detected Ebola in 13 of 20 samples tested. Early results indicate a non-Zaire ebolavirus; sequencing confirmed the Bundibugyo strain. As of May 15, 2026: 246 suspected cases; 65 deaths — mainly in Mongwalu and Rwampara health zones; 4 deaths confirmed by laboratory testing. Suspected cases also reported in Bunia (Ituri capital), pending confirmation.

📊 Cross-Border Spread — Uganda Confirmed Case · Al Jazeera / CNN / CIDRAP · May 15, 2026

Uganda confirmed the first cross-border Ebola case on May 15, 2026 — a 59-year-old Congolese man admitted to Kibuli Muslim Hospital, Kampala on May 11 with fever, nausea, and respiratory distress. He deteriorated and died in ICU on May 14, 2026 with bleeding symptoms. Uganda's lab confirmed Bundibugyo ebolavirus. His body was transported back to DRC. Uganda has screened at 22 entry points and activated its Emergency Operations Centre. No locally transmitted cases confirmed yet in Uganda.

📊 Africa CDC Emergency Meeting · Africa CDC Press Release · May 15, 2026

Africa CDC Director General Dr. Jean Kaseya convened an urgent high-level coordination meeting on May 15, 2026 with health authorities from DRC, Uganda, and South Sudan, plus global partners including: WHO, UNICEF, FAO, US CDC, EU CDC, China CDC, Public Health Agency of Canada, MSF, IFRC, World Bank, Gavi, CEPI, Gates Foundation, Wellcome Trust, Merck, J&J, Roche, BioNTech, Moderna, Regeneron. Focus: cross-border coordination, surveillance, laboratory support, IPC (Infection Prevention and Control), risk communication, Safe and Dignified Burials, and resource mobilisation.

📊 WHO Response — Funding & Team Deployment · CIDRAP / WFMD · May 15, 2026

WHO Director-General Tedros Adhanom Ghebreyesus confirmed WHO was first notified of suspected cases on May 5, 2026; WHO experts arrived in Ituri by May 8. DRC has a "strong track record" in Ebola response (Tedros). WHO released $500,000 in emergency funding. DRC has stockpiles of Ebola treatments and ~2,000 doses of Ervebo — but officials cautioned these are effective only against the Zaire strain, not Bundibugyo.

📊 Vaccine Gap — The Central Challenge · Direct Relief / CIDRAP · May 15, 2026

This is the 3rd ever Bundibugyo ebolavirus outbreak (after Uganda 2007 and DRC 2012). It is already the largest Bundibugyo outbreak in history. No approved vaccine or specific treatment exists for Bundibugyo. CEPI (Coalition for Epidemic Preparedness Innovations) stated it is "standing by to provide R&D support including facilitating clinical trials." Scientists note Bundibugyo and Zaire ebolaviruses are ~40% genetically different, making vaccine cross-protection impossible.

📊 Previous DRC Outbreak Declared Over · WHO / The Deep Dive · December 1, 2025

The DRC's 16th Ebola outbreak in Kasai Province (Zaire strain) was declared over by WHO on December 1, 2025 after 64 total cases (53 confirmed, 11 probable) and 45 deaths. The final patient was discharged on October 19, 2025. The gap between outbreaks was approximately 5 months. The 2026 Ituri outbreak is the 17th and involves a different province and a different strain.

📊 India's BSL-4 Progress · Vajiram & Ravi / MoHFW · January 2026

India's first state-funded BSL-4 lab — spread over 11,000 sq metres, costing ₹362 crore — had its foundation stone laid on January 13, 2026 in Gandhinagar, Gujarat by Home Minister Amit Shah. It will operate under the Gujarat Biotechnology Research Centre (GBRC) and function as a national designated facility. India's only existing BSL-4 lab is at NIV Pune. This is critical for India's preparedness against pathogens like Ebola, Nipah, and Marburg.

💡 Exam Tip — Pre-Exam Watch Points

Watch for: (1) Whether WHO declares a PHEIC for this outbreak; (2) Any emergency vaccine trials for Bundibugyo launched by CEPI; (3) Whether South Sudan reports any cases; (4) India's MoHFW travel advisory for East Africa. These are live developments that may be tested in UPSC 2026 Prelims (May 25, 2026 — just 10 days away!).

Bottom Line: DRC 17th outbreak confirmed May 15, 2026; Bundibugyo strain; 246 suspected / 65 deaths; Uganda confirmed cross-border case (Kampala, May 14); no vaccine for Bundibugyo; Africa CDC convened emergency meeting; WHO deployed team and released $500K; India's BSL-4 lab (Gujarat) foundation laid January 2026.

PYQ & Common Traps

Statement True/False Table — UPSC Style

Test each statement before looking at the answer
Statement	T/F	Explanation
Ebola virus belongs to the family Paramyxoviridae	❌ FALSE	Ebola belongs to Filoviridae. Paramyxoviridae = Nipah, Measles, Mumps.
Reston ebolavirus is known to cause fatal disease in humans	❌ FALSE	Reston ebolavirus is NOT pathogenic to humans — only to macaques. It was found in Philippines-imported monkeys.
The 2014–16 West Africa Ebola epidemic was the largest in history	✅ TRUE	28,600+ cases, 11,325+ deaths. Larger than 2018–20 DRC (3,470 cases).
Ervebo vaccine protects against all Ebola species	❌ FALSE	Ervebo targets only Zaire ebolavirus. No protection against Bundibugyo or Sudan strains.
Africa CDC is a specialised organ of the World Health Organization	❌ FALSE	Africa CDC is an autonomous institution of the African Union (AU), not WHO. Headquartered in Addis Ababa.
Ebola can spread through the air like influenza	❌ FALSE	Ebola spreads only through direct contact with body fluids. It is NOT airborne.
Bundibugyo ebolavirus was first discovered in Uganda	✅ TRUE	First identified in 2007 in Bundibugyo District, Uganda. Named after the district.
The natural reservoir of Ebola is the fruit bat (Pteropodidae)	✅ LIKELY TRUE	Fruit bats are the probable reservoir — not definitively confirmed for all species, but WHO/CDC consensus. Do not say "confirmed" — say "probable".
India's first BSL-4 laboratory is located in Gujarat	❌ FALSE	India's first BSL-4 lab is at NIV Pune. Gujarat (Gandhinagar) is the first state-funded BSL-4, under construction (foundation stone January 2026).
The 2026 Ituri outbreak is DRC's 17th Ebola outbreak since 1976	✅ TRUE	Confirmed by CIDRAP, Africa CDC, WHO. The 16th was in Kasai Province (declared over December 1, 2025).

⚠ Trap 1 — Family Confusion

Students confuse Filoviridae (Ebola, Marburg) with Paramyxoviridae (Nipah, Hendra, Measles) and Coronaviridae (COVID-19, SARS, MERS). All three are RNA viruses causing serious disease — but the family names are different. UPSC frequently tests this in multi-option statements.

⚠ Trap 2 — Africa CDC vs WHO

Africa CDC ≠ WHO. Africa CDC is an African Union institution; WHO is a United Nations agency. Africa CDC declares PHECS (continental emergency); WHO declares PHEIC (international emergency). Students often attribute WHO's PHEIC power to Africa CDC.

⚠ Trap 3 — Outbreak Ranking

Largest overall = 2014–16 West Africa. Second largest = 2018–20 DRC. Largest ever in DRC = 2018–20. Students reverse these. Also: the 2026 Ituri outbreak is the largest Bundibugyo outbreak — but far smaller overall than the Zaire-strain outbreaks.

⚠ Trap 4 — Bundibugyo Vaccine Myth

Ervebo was used successfully in the 2018–20 DRC outbreak — students incorrectly assume it will be used for 2026 Ituri. It cannot: the 2026 outbreak is Bundibugyo strain; Ervebo only covers Zaire. This is the defining challenge of 2026 that examiners will test.

⚠ Trap 5 — Reservoir Certainty

Fruit bats (Pteropodidae) are the probable natural reservoir — this is not proven with certainty for all species. UPSC options may use "confirmed" vs "suspected/probable" — choose "probable" not "confirmed". Never say bats are the "definitive" reservoir.

⚠ Trap 6 — BSL-4 India Location

India's FIRST BSL-4 lab = NIV Pune (National Institute of Virology). India's FIRST STATE-FUNDED BSL-4 = Gandhinagar, Gujarat (under construction, foundation January 2026). Students confuse the two or say "India has no BSL-4 lab."

💡 PYQ Pattern — UPSC 2021 Prelims (Official)

UPSC asked about Recombinant Vector Vaccines in 2021 — directly relevant to Ervebo (rVSV-ZEBOV = a recombinant vesicular stomatitis virus). The exam also previously tested: "Which of the following is NOT transmitted through mosquito bites?" — Ebola is the correct answer (body fluid transmission only). Know the transmission clearly.

Bottom Line: 6 main traps: family (Filoviridae not Paramyxoviridae); Africa CDC ≠ WHO; 2014–16 > 2018–20 by size; Ervebo = Zaire only (useless for Bundibugyo 2026); reservoir = "probable" fruit bat; India BSL-4 = NIV Pune (not Gujarat — that's under construction).

MCQ Practice

1Consider the following statements about Ebola Virus Disease (EVD):
1. Ebola virus belongs to the family Filoviridae.
2. The natural reservoir of Ebola is the fruit bat of family Pteropodidae.
3. Ebola can spread through contaminated water and mosquito bites.
4. The case fatality rate for Zaire ebolavirus ranges from 60–90%.
Which of the above statements are correct?

Correct: (a) 1, 2 and 4 only

Statement 1 ✅ — Ebola belongs to Filoviridae (not Paramyxoviridae). Statement 2 ✅ — Pteropodidae fruit bats are the probable natural reservoir. Statement 3 ❌ — Ebola does NOT spread through water or mosquitoes; only direct contact with body fluids. Statement 4 ✅ — Zaire CFR is ~60–90%, the highest of all species. Note: Statement 2 uses "probable" — the WHO/CDC consensus position.

2Which of the following Ebola vaccine(s) is/are WHO-prequalified and licensed for use during active outbreaks?
1. Ervebo (rVSV-ZEBOV) by Merck
2. Zabdeno/Mvabea by Janssen
3. A candidate vaccine for Bundibugyo ebolavirus
Select the correct answer:

Correct: (c)

Ervebo (rVSV-ZEBOV) = single dose, WHO-recommended for ring vaccination during active outbreaks (SAGE 2024). Zabdeno/Mvabea = 2 doses 56 days apart, WHO prequalified but recommended for preventive use (frontline workers), not outbreak ring vaccination. No licensed vaccine exists for Bundibugyo ebolavirus. All current vaccines target Zaire ebolavirus only.

3With reference to Africa CDC (Africa Centres for Disease Control and Prevention), which of the following statements is/are correct?
1. It is a specialised autonomous institution of the African Union (AU), headquartered in Addis Ababa.
2. It was proposed by the government of Nigeria at a 2013 AU summit.
3. In 2022, its statute was revised to grant it the power to declare Public Health Emergencies of Continental Security (PHECS).
4. The 2014 West Africa Ebola epidemic accelerated its creation.

Correct: (c) 1, 3 and 4 only

Statement 1 ✅ — Africa CDC is an AU autonomous institution, HQ Addis Ababa. Statement 2 ❌ — The concept was proposed by Ethiopia (not Nigeria) in 2013 at the TB/HIV Special Summit in Abuja, Nigeria. Statement 3 ✅ — 2022 revised statute granted Africa CDC power to declare PHECS (used for 2024 mpox). Statement 4 ✅ — 2014 West Africa Ebola epidemic was the primary catalyst for fast-tracking Africa CDC's creation.

4The 2026 Ebola outbreak in the Ituri Province of DRC has drawn attention because:
1. It involves the Bundibugyo strain for which no licensed vaccine exists.
2. The outbreak has already spread to Uganda, confirming cross-border transmission.
3. The affected health zones of Mongwalu and Rwampara border both Uganda and South Sudan.
4. The Ervebo vaccine has been deployed and is expected to contain the outbreak rapidly.
Select the correct answer:

Correct: (b) 1, 2 and 3 only

Statement 1 ✅ — Bundibugyo strain confirmed; no approved vaccine. Statement 2 ✅ — Uganda confirmed a Congolese man died of Bundibugyo Ebola in Kampala on May 14, 2026. Statement 3 ✅ — Ituri Province borders Uganda and South Sudan. Statement 4 ❌ — Ervebo is NOT useful for Bundibugyo (targets Zaire strain only). DRC has ~2,000 Ervebo doses but officials confirmed they cannot be used for this outbreak.

5Arrange the following Ebola outbreaks in ascending order of number of total confirmed cases:
I. 2007 Bundibugyo, Uganda
II. 1995 Kikwit, DRC
III. 2018–2020 DRC (10th outbreak)
IV. 2014–16 West Africa epidemic

Correct: (a) I → II → III → IV

2007 Bundibugyo Uganda: 56 cases → 1995 Kikwit DRC: 315 cases → 2018–20 DRC: 3,470 cases → 2014–16 West Africa: 28,600+ cases. This is a common chronological/quantity-based UPSC Prelims question. Remember: 2014–16 West Africa is always the LARGEST; 2018–20 DRC is the SECOND LARGEST overall but the LARGEST EVER in DRC alone.

Bottom Line: MCQ focus areas: Filoviridae family; Ervebo = Zaire only; Africa CDC = AU (HQ Addis Ababa; proposed by Ethiopia); Bundibugyo 2026 = no vaccine; ascending order 2007(56) < 1995(315) < 2018–20(3,470) < 2014–16(28,600+).

Quick Revision

⚡ Rapid Recall — Ebola Virus Disease & 2026 Ituri Outbreak (Environment · Prelims)

Family: Filoviridae · Order: Mononegavirales · Genome: ssRNA (negative-sense) · BSL-4 pathogen
5 species: Zaire (most lethal, CFR 60–90%), Sudan (CFR 40–60%), Bundibugyo (CFR ~33%), Taï Forest (1 case only), Reston (NOT human-pathogenic)
Reservoir: Probable natural reservoir = fruit bats (Pteropodidae) — NOT confirmed definitively
Transmission: Body fluids ONLY — NOT airborne, NOT waterborne, NOT mosquito-borne; incubation 2–21 days; no carrier state
First identified: 1976, simultaneously in Zaire (now DRC) and Sudan (now South Sudan); named after Ebola River
Largest outbreak: 2014–16 West Africa (28,600+ cases, 11,325 deaths) — PHEIC Aug 2014; 2nd largest = 2018–20 DRC (3,470 cases)
2026 Ituri outbreak: DRC's 17th outbreak; Bundibugyo strain; 246 suspected / 65 deaths; already spread to Uganda (Kampala); confirmed May 15, 2026
Vaccine gap: Ervebo (rVSV-ZEBOV, Merck) + Zabdeno/Mvabea (J&J) = only for Zaire strain; NO vaccine for Bundibugyo — 2026 outbreak cannot use existing stocks
Africa CDC: AU autonomous institution; HQ Addis Ababa; proposed by Ethiopia 2013; formally launched 2017; DG = Dr. Jean Kaseya; declares PHECS (not PHEIC — that's WHO)
Key India angle: India's first state-funded BSL-4 lab foundation stone laid January 13, 2026 in Gandhinagar, Gujarat; India's first BSL-4 = NIV Pune
Ituri geography: Northeast DRC; capital = Bunia; borders Uganda & South Sudan; 1,000+ km from Kinshasa; Mongwalu = gold mining zone; ADF militants active
Bundibugyo history: 3rd ever outbreak (first = Uganda 2007, 56 cases; second = DRC 2012, 57 cases; third = 2026 Ituri, 246+ — already the largest)

🎯 One-Liner: Ebola (Filoviridae, BSL-4) → 2026 Ituri = DRC's 17th outbreak, Bundibugyo strain, NO vaccine, already in Uganda → Africa CDC (AU, Addis Ababa) called emergency meeting May 15, 2026.

· MaargX UPSC · Curated for Civil Services Preparation ·

Strain Comparison Quick Matrix

5-species cheatsheet — print and revise
Species	CFR	Found	Vaccine	2026 Outbreak?
Zaire	60–90%	DRC 1976	✅ Ervebo + Zabdeno/Mvabea	No (previous outbreaks used these)
Sudan	40–60%	Sudan 1976	❌ None (trials)	No
Bundibugyo	25–40%	Uganda 2007	❌ None	YES — Ituri 2026
Taï Forest	0% (1 case)	Côte d'Ivoire 1994	❌ None	No
Reston	N/A (not human)	USA/Philippines 1989	N/A	No

Institutions Cheatsheet

Key institutions for EVD response — Prelims rapid recall
Institution	Parent	HQ	Role
Africa CDC	African Union	Addis Ababa	Continental coordination; declares PHECS
WHO	United Nations	Geneva	Global coordination; declares PHEIC
INRB	DRC Govt	Kinshasa	National biomedical research; confirmed 2026 outbreak
CEPI	Global PPP	Oslo	Vaccines R&D for epidemic pathogens
Gavi	Global PPP	Geneva	Vaccine procurement; ICG stockpile access
ICG	WHO/UNICEF/MSF	—	International Coordinating Group; manages Ervebo stockpile

★ Important — UPSC 2026 Pre-Exam

UPSC Prelims 2026 is on May 25, 2026 — just 10 days after this Ituri outbreak was confirmed. This is an extremely high-probability current affairs topic. Expect 1–2 questions on: (1) strain/vaccine gap (Bundibugyo + no vaccine), (2) Africa CDC identity (AU institution, Addis Ababa), (3) DRC outbreak count (17th), (4) Filoviridae family. Revise this panel twice.